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Fasciolosis, caused by Fasciola hepatica and Fasciola gigantica, is a trematode zoono-
sis of interest in public health and livestock production. Like other helminths, F. hepatica 
modulates the host immune response by inducing potent polarized Th2 and regulatory 
T cell immune responses and by downregulating the production of Th1 cytokines. In this 
work, we show that F. hepatica glycans increase Th2 immune responses by immuno-
modulating TLR-induced maturation and function of dendritic cells (DCs). This process 
was mediated by the macrophage Gal/GalNAc lectin (MGL) expressed on DCs, which 
recognizes the Tn antigen (GalNAc-Ser/Thr) on parasite components. More interestingly, 
we identified MGL-expressing CD11c+ cells in infected animals and showed that these 
cells are recruited both to the peritoneum and the liver upon F. hepatica infection. These 
cells express the regulatory cytokines IL-10, TNFα and TGFβ and a variety of regulatory 
markers. Furthermore, MGL+ CD11c+ cells expand parasite-specific Th2/regulatory cells 
and suppress Th1 polarization. The results presented here suggest a potential role of 
MGL in the immunomodulation of DCs induced by F. hepatica and contribute to a better 
understanding of the molecular and immunoregulatory mechanisms induced by this 
parasite.
Keywords: helminth, dendritic cell, c-type lectin receptors, glycans, macrophage gal/galnac lectin, immune 
regulation
inTrODUcTiOn
Fasciola hepatica is a worldwide-distributed parasitic flatworm that causes fasciolosis, a zoonotic 
disease that affects mainly livestock and causes significant economic losses worldwide (1). In 
addition, the World Health Organization (WHO) estimates that around 2.5 million people 
are infected around the world and several millions are at risk (1). Like other helminths, F. 
hepatica modulates the host immune response by inducing potent polarized Th2 and regulatory 
T  cell immune responses and by downregulating the production of Th1 cytokines (2–5). This 
immunoregulated environment favors the differentiation of regulatory T cells (3), the alternative 
activation of macrophages (5), and the modulation of the activity of both dendritic cells (DCs) 
and mast cells (2, 6–8). Helminths express carbohydrate-containing glycoconjugates on their 
surface and they release glycan-rich excretion/secretion products that can be very important 
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in their life cycles and pathology, since they can participate in 
immune escape (9). In this context, we have recently described 
that glycans structures produced by F. hepatica participate in 
the modulation of DC maturation and mediate the production 
of IL-10 and IL-4 during infection (10).
Parasite glycans are recognized by the immune system 
through the interaction of C-type lectin receptors (CLRs), a 
large family of calcium-dependent glycan-binding proteins 
that present structural homology in their carbohydrate 
recognition domain (11). Several reports have highlighted 
the role of CLRs in mediating the internalization of parasite 
glycoconjugates and cell-surface signaling, leading to a modu-
lation of the host immune response (12–14). Macrophage Gal/
GalNAc lectin (MGL), also known as CLEC4A or CD301, is 
a type II transmembrane protein expressed on professional 
antigen-presenting cells (15, 16). MGL displays a remarkable 
specificity for terminal N-acetyl-galactosamine (GalNAc) 
moieties, including the Tn antigen (αGalNAc-O-Ser/Thr) and 
LacDiNAc (GalNAcβ1-4GlcNAc, LDN). While there is only 
one MGL in humans (hMGL), two orthologs are present in 
mice, mMGL1 (CD301a) and mMGL2 (CD301b), which dif-
fer in their glycan specificity (17, 18). Interestingly, although 
mMGL1 is more structurally similar to hMGL, mMGL2 and 
hMGL display similar ligand specificity (19). In contrast, 
mMGL1 recognizes the Lewisx [Galβ1–4(αFuc1–3)GlcNAc] 
and Lewisa [Galβ1–3(αFuc1–4)GlcNAc] antigens. Several 
reports have demonstrated that both human and murine MGL 
can recognize glycoconjugates present in helminth parasites, 
such as Schistosoma mansoni (20), Trichuris suis (21), and 
Taenia crassiceps (22). Furthermore, it has been proposed that 
MGL2+ dermal DCs are specialized in the induction of Th2 
responses both in allergy and helminth-infection models (22).
Given that F. hepatica glycans modulate DC maturation 
inducing a Th2/regulatory-polarized immune response (2–5) and 
our group has previously identified the Tn antigen expressed on 
F. hepatica glycoconjugates (23), the simplest mucin type 
O-glycan structure composed of N-acetyl-d-galactosamine with 
a glycosidic α-linkage to serine/threonine residues in glycopro-
teins (17, 23), we set out to evaluate the potential role of MGL 
in the recognition of parasite glycans as well as a mediator of F. 
hepatica-induced immunoregulation.
Our results indicate that the Tn antigen expressed by 
F. hepatica can modulate the TLR2-induced maturation 
of human monocyte-derived DCs (mo-DCs) in a process 
mediated by hMGL by upregulating the production of IL-10 
and TNFα. Furthermore, we show that mMGL2+ CD11c+ 
F4/80lo cells are recruited to the peritoneum of infected mice. 
Interestingly, these cells express the regulatory cytokines 
IL-10, TNFα, and TGFβ and a variety of regulatory markers. 
The results presented here constitute the first report about 
the participation of mMGL2+ CD11c+ in the expansion of 
Th2/regulatory-immune responses and in the suppression of 
Th1 polarization during an helminth infection, suggesting a 
potential role of MGL in the immunomodulation induced by 
F. hepatica and contribute to a better understanding of the 
molecular and immunoregulatory mechanisms induced by 
this parasite.
MaTerials anD MeThODs
ethics statement
Mouse experiments were carried out in accordance with strict 
guidelines from the National Committee on Animal Research 
(Comisión Nacional de Experimentación Animal, CNEA, http://
www.cnea.org.uy, National Law 18.611, Uruguay) according 
to the international statements on animal use in biomedical 
research from the Pan American Health Organization and WHO. 
Adult worms were collected from bovine livers during the routine 
work of a local abattoir (Frigorífico Carrasco) in Montevideo 
(Uruguay). Protocols were approved by the Uruguayan Committee 
on Animal Research (Comisión Honoraria de Experimentación 
Animal, CHEA Protocol Numbers: 071140-001822-11 and 
071140-000143-12).
Mice
Six- to eight-week-old female BALB/c mice were obtained from 
DILAVE Laboratories (Uruguay). Animals were kept in the 
animal house (URBE, Facultad de Medicina, UdelaR, Uruguay) 
with water and food supplied ad  libitum, mouse handling and 
experiments were carried out in accordance with strict guidelines 
from the National Committee on Animal Research (Comisión 
Nacional de Experimentación Animal, CNEA, National Law 
18.611, Uruguay). Adult worms were collected during the routine 
work of a local abattoir (Frigorífico Carrasco) in Montevideo 
(Uruguay). All procedures involving animals were approved by 
the Universidad de la República’s Committee on Animal Research 
(Comisión Honoraria de Experimentación Animal, CHEA 
Protocol Numbers: 071140-001822-11 and 071140-000143-12).
Preparation of Protein lysates from  
F. hepatica
Live adult worms of F. hepatica were obtained from the bile ducts 
of bovine livers, washed in phosphate-buffered saline (PBS) pH 
7.4, then mechanically disrupted and sonicated. After centrifuga-
tion at 40,000 × g for 60 min, supernatants were collected and 
dialyzed against PBS. The obtained lysate (FhTE) was quantified 
and stored at −80°C. The endotoxin levels were determined by 
using the Limulus Amebocyte Lysate kit Pyrochrome (Associates 
of Cape Cod). Protein preparations showed very low levels of 
endotoxins and were not able to induce DC maturation on their 
own. The concentration of all F. hepatica extracts used in culture 
experiments did not induce signaling through TLR4 or TLR2 nor 
modify cell viability of moDCs evaluated by flow cytometry, as 
shown in Figure S1 in Supplementary Material. For a tegumental 
extract of F. hepatica, adult worms were incubated in 1% deoxy-
cholic acid in 0.15 M glycine (pH 9.0), 0.5 M NaCl for 60 min 
at 37°C. The deoxycholate extracted material was centrifuged at 
20,000 × g for 60 min, dialyzed against PBS, and stored at −80°C 
until used.
cells
Monocytes were isolated from peripheral blood mononuclear 
cells from buffy coats of healthy human donors (Sanquin, The 
Netherlands) by a lymphoprep gradient (Axis-Shield, San Diego, 
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CA, USA) and subsequent percoll gradient centrifugation (GE 
Healthcare Life Science, Netherlands). Informed consent was 
obtained from all blood donors. DCs were generated by cultur-
ing purified monocytes in complete medium consisting of RPMI 
1,640 (Thermo Fisher Scientific, Netherlands) supplemented 
with 10% fetal bovine serum (BioWhittaker), 1,000 U/ml peni-
cillin/streptomycin (Lonza, Netherlands), and 2 mM glutamine 
(Lonza, Netherlands) in combination with IL-4 (262.5  U/ml; 
Biosource, Belgium) and GM-CSF (112.5  U/ml; Biosource, 
Belgium) for 4–5  days. After that time, cells were harvested 
and MGL expression was confirmed by flow cytometry using 
a specific hMGL antibody (1G6.6) (24). For DC-maturation 
assays, mo-DCs (2 × 105/well) were incubated at 37°C and 5% 
CO2 in 96-well plates with plate-bound FhTE (125 μg/ml) in the 
presence or absence of Pam3CysK4 (TLR1/2, 10 μg/ml) or LPS 
(TLR4, 10 ng/ml). When appropriate, DCs were preincubated for 
60 min at 37°C with the blocking anti-MGL antibody (1G6.6). 
IL-6, IL-10, and TNFα levels were determined by specific ELISAs 
(eBiosciences, CA or BioSource, Belgium) after overnight 
incubation.
HEK293-TLR2 and HEK293-TLR4/MD2 co-transfectants 
were grown in RPMI-1640 supplemented with 10% fetal calf 
serum, 104  U/ml penicillin, 104  U/ml streptomycin, 2  mM 
l-glutamine, and 1 mg/ml G418 (Invitrogen) overnight at 37°C. 
For LPS or Pam3CSK4 content determination, a total of 105 cells 
in 100 μl RPMI were plated onto 96-well flat-bottom plates and 
stimulated with a titration of LPS (20–1  ng/ml) or Pam3CSK4 
(50–1 μg/ml). Subsequently, supernatants were analyzed for IL-8 
production by ELISA.
naïve cD4 T Polarization assay
Monocyte-derived DCs were stimulated with plate-bound FhTE 
in the presence or absence of LPS (10 ng/ml). After 48 h, expres-
sion of costimulatory molecules was measured by flow cytom-
etry using the following antibodies: anti-CD86 (BU63), -CD83 
(HB15e), -HLA-DR (L203), -CD40 (5C3), and -OX40L (Ik-1).
After stimulation, cells were washed and cocultured with 
allogenic naïve CD4 T cells (CD4+ CD45RA+, ratio 1:10), puri-
fied by MACS Beads (Miltenyi), in the presence of Staphylococcal 
Enterotoxin B (10 pg/ml, Sigma). On day 5, supernatants were 
harvested (for evaluation of IFNγ) and replaced with rhuIL-2 
(100 U/ml, immunotools). Primed CD4+ T cells were stimulated 
with a cocktail containing 100  ng/ml Phorbol 12-myristate 
13-acetate, 1  μg/ml ionomycin, and 10  μg/ml brefeldin A for 
5–6 h. The cells were washed, fixed, and permeabilized using the 
Cytofix/Cytoperm kit (BD Biosciences) and subsequently stained 
with a combination of IL-4-PE and IFN-γ-FITC antibodies (BD 
Biosciences).
clr-Fc Binding assay
NUNC maxisorp plates (Roskilde, Denmark) were coated with 
FhTE (125  μg/ml) overnight at 4°C. Plates were blocked with 
1% bovine serum albumin (BSA) in TSM (20 mM Tris, pH 7.4, 
150 mM NaCl, 1 mM CaCl2, and 2 mM MgCl2), and 1 μg/ml of 
different hCLR-Fc in TSM were added for 2 h at room tempera-
ture. Specific binding was blocked through the preincubation of 
hCLR-Fc with the Ca2+-chelator EGTA (10 mM). For hMGL-Fc, 
the specific binding was blocked with free GalNAc (100  mM; 
Sigma-Aldrich) or blocking anti-hMGL antibody (1G6.6, 10 μg/
ml), by preincubation for 30 min at 37°C. Binding was detected 
using a peroxidase-labeled, anti-human IgG-Fc antibody (Jackson 
ImmunoResearch Laboratories, PA, USA). Binding was visual-
ized with 3,3′,5,5′-tetramethylbenzidine (TMB) as a substrate 
(Sigma-Aldrich), and optical density was measured by spectro-
photometry at 450  nm. When indicated, FhTE was pretreated 
with the enzymes α-N-acetylgalactosaminidase or α-manosidase 
(Prozyme, CA, USA), as indicated in manufacturer’s instructions.
Western Blot
Proteins in FhTE were separated in a 15% SDS-PAGE and trans-
ferred to nitrocellulose sheets (Amersham, Saclay, France) at 45 V 
overnight in 20 mM Tris–HCl, pH 8.3, 192 mM glycine, and 10% 
ethanol. Residual protein-binding sites were blocked by incuba-
tion with 1% BSA in TSM at 37°C for 1  h. The nitrocellulose 
was then incubated for 1 h at room temperature with hMGL-, 
mMGL1-, or mMGL2-Fc in TSM. After three washes with TSM 
containing 0.1% Tween-20, the membrane was incubated for 1 h at 
room temperature with a peroxidase-labeled anti-human IgG-Fc 
antibody. For the oxidation of the glycan moieties of FhTE, strips 
were treated with 10  mM of sodium metaperiodate in 50  mM 
sodium acetate buffer pH 4.5 for 30 min at room temperature in 
the dark, washed with 50 mM sodium acetate buffer, and subse-
quently incubated for 1 h with glycine 1% at room temperature. 
As control, strips were subjected to the same treatment except for 
the incubation with sodium metaperiodate.
infections and cell cultures
Each BALB/c mouse was orally infected with 10 F. hepatica 
metacercariae (Baldwin Aquatics, USA). At 3 weeks postinfection 
(wpi), peritoneal exudates cells (PECs), spleens, and livers were 
removed. PECs were harvested by washing the peritoneal cavity 
with 5 ml of cold PBS. Purified CD11c+ cells from PECs of infected 
and non-infected animals were obtained by positive selection 
(StemCell Technologies, Canada). In all cases, a purity >90% was 
obtained. CD11c+ cells were stimulated with plate-bound FhTE, 
as indicated above. For mixed lymphocyte reactions, splenic CD4+ 
T cells were purified from C57BL/6 mice. For syngenic stimula-
tion, purified splenic CD4+ T cells from BALB/c-infected animals 
sacrificed at 3 wpi were used. CD4+ T cells were cultured with 
stimulated CD11c+ cells for 5 days at 37°C and 5% CO2. IFN-γ 
and IL-10 levels were then quantified in the culture supernatants. 
Alternatively, cells were additionally stimulated with Pam2CysK4 
(1 μg/ml) for 2 days at 37°C and 5% CO2.
Peritoneal exudate cells from infected and non-infected mice 
were washed twice with PBS containing 2% FBS and 0.1% sodium 
azide. The following antibodies were used in these experiments: 
anti-CD8 (53-6.7), -CD11c (N418), -I-A/I-E (2G9), -F4/80 
(BM8), -CD86 (GL1), -CD11b (M1/70), -SIRPα (P84), -Ly6G 
(RB6-8C5), -Ly6C (HK1.4), -Siglec-F (E50-2440), -mMGL1 
(LOM-8.7), and -mMGL2 (URA-1). Cells were then washed 
twice with PBS containing 2% FBS and 0.1% sodium azide and 
fixed with 1% formaldehyde. Cell populations were analyzed 
using a BD FACSCalibur (BD Biosciences). Antibodies were 
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obtained from Affymetrix (CA, USA) or BD-Biosciences (CA, 
USA). IL-10 and IL-12/IL23p40 in vivo production and expres-
sion of CD68 (FA-11) were analyzed by intracellular staining. 
PECs from infected and non-infected mice were cultured for 6 h 
with GolgiPlug (BD Biosciences) when needed, washed, stained 
with CD11c, and then fixed and permeabilized using the Cytofix/
Cytoperm kit (BD Biosciences) and subsequently stained with 
Abs specific for IL-12/23p40 or IL-10 (Biolegend, CA, USA).
internalization assay
The internalization and binding of FhTE to CD11c+ cells in 
PECs were analyzed by flow cytometry. Briefly, PECs (1 × 105/
well) were incubated with Alexa 647-labeled FhTE for 1 h at 37°C 
in complete medium (to assess uptake), or at 4°C in complete 
medium (to assess binding). Cells were then washed twice and the 
binding or internalization by CD11c+ cells was analyzed by FACS.
Quantitative real-time rT-Pcr
Total RNA was isolated from spleen, liver, and purified CD11c+ 
cells from PEC by using Tri-reagent (Sigma-Aldrich). Quantitative 
real-time PCR was performed in StepOne™ real-time PCR 
system (Applied Biosystems) using Fast SYBR® Green Master 
Mix (Applied Biosystems) (25). The reactions were performed 
according to the following settings: 95°C for 20 s min for initial 
activation, followed by 40 thermal cycles of 3 s at 95°C, and 30 s 
at 60°C. All reactions were performed with five biological and two 
technical replicates with negative controls.
Microscopy analyses
Livers from infected mice after 3  wpi or naive mice (control) 
were harvested, embedded in OCT, and snap frozen in nitrogen. 
Sections were cut at a thickness of 8 μm, fixed with cold acetone 
for 10 min, and blocked with 5% BSA in 3% rat serum for 1 h at 
room temperature. Sections were then overnight incubated at 4°C 
with anti-mMGL2 (URA-1), -cCD11c (N418), and -F4/80 (BM8), 
stained with 4′,6-diamidino-2-phenylindole and visualized in 
an epifluorencense microscope Olympus IX-81 and confocal 
microscope Leica TCS-SP5-II.
statistical analysis
Results were analyzed using a one-way ANOVA followed by 
Bonferroni Multiple Comparison test or a student’s t-test using 
GraphPad Prism software (GraphPad Software, San Diego, CA, 
USA). Results were considered to be significantly different when 
p < 0.05.
resUlTs
F. hepatica glycoconjugates Potentiate 
the Tlr2- and Tlr4-induced Production 
of TnFα and il-10 by mo-Dcs via hMgl
Several studies have demonstrated that different parasites 
modulate the host immune response through the interaction 
with CLRs expressed on immune cells (16, 18, 26). In order to 
evaluate the involvement of different CLRs in the recognition of 
F. hepatica glycoconjugates, we performed an ELISA-like assay 
coating F. hepatica components on the plate and further incubat-
ing them with a variety of CLRs-Fc fusion proteins. FhTE was 
highly recognized by hMGL and, to a lower extent, by Mannose 
receptor (MR), DC-SIGN, and DCIR, while it was not recognized 
by Dectin-1 or Langerin (Figure 1A). As expected, the observed 
CLR binding was abrogated in presence of the chelating agent 
EGTA, indicating that divalent cations such as Ca2+ are essential 
for this interaction/binding.
Given that hMGL strongly interacted with FhTE and that 
hMGL triggering modulates the TLR-induced maturation of 
mo-DCs (27), we sought to evaluate whether FhTE was able 
to modulate DC maturation via this CLR. To this end, we first 
confirmed the expression of hMGL on mo-DCs (Figure  1B). 
mo-DCs were then cultured on FhTE-coated plates in the pres-
ence or absence of Pam3CSK4 (TLR1/2 ligand) or LPS (a TLR4 
ligand), and the production of different cytokines was evaluated 
in the culture supernatants. Although FhTE did not induce the 
expression of TNFα, IL-6, and IL-10, it enhanced the produc-
tion of TNFα and IL-10, but not IL-6, by Pam3CSK4- and LPS-
stimulated mo-DCs (Figure  1C). Interestingly, an anti-hMGL 
blocking antibody abrogated the enhanced production of TNFα 
and IL-10, indicating that there is a crosstalk between TLR1/2/4 
and hMGL in the presence of parasite components (Figure 1D). 
Of note, the hMGL-mediated crosstalk was only detected when 
mo-DCs were cultured with immobilized, but not soluble, FhTE 
(Figure S2 in Supplementary Material), suggesting that hMGL 
cross-linking is required for triggering or that internalization is 
dispensable for hMGL triggering, as already reported for other 
hMGL ligands (28).
Triggering of Mgl by F. hepatica antigens 
induce Th2 Polarization by reduction  
of iFnγ
Next, we evaluated whether MGL triggering by F. hepatica 
on DCs could modulate the differentiation of T  cells. Thus, 
we analyzed the costimulatory markers on LPS-matured mo-
DCs conditioned with F. hepatica components. Interestingly, 
FhTE was unable to induce any change in the expression of 
costimulatory markers on LPS-matured mo-DCs (Figure 2A). 
However, these DCs induced lower production of IFNγ by 
stimulated T  cells in a dose-dependent manner as compared 
to control LPS-matured mo-DCs (Figure 2B). In addition, the 
reduced capacity to induce IFNγ-producing T cells by FhTE/
LPS-matured mo-DCs was abrogated by the anti-MGL anti-
body (Figure 2C). Finally, mo-DCs matured in the presence of 
LPS and FhTE polarized T cells toward a Th2 phenotype, since 
they produced higher IL-4/IFNγ ratio than LPS-stimulated 
mo-DCs (Figures 2D–E). Importantly, the capacity of FhTE/
LPS-stimulated mo-DCs to induce Th2 polarization was medi-
ated by MGL since a specific anti-MGL antibody abrogated this 
process (Figure 2F).
hMgl interacts with the Tn antigen 
Present on FhTe
To identify the nature of F. hepatica glycoconjugates recognized 
by hMGL, we carried out binding inhibition assays and selective 
FigUre 1 | Macrophage gal/galnac lectin recognizes F. hepatica glycoconjugates and potentiates the production of il-10 and TnF-α by 
Pam3csK4-stimulated monocyte-derived Dcs (mo-Dcs). (a) Binding of different hCLR-Fc on FhTE-coated plates in presence (white bars) or absence (black 
bars) of EGTA. (B) Expression of hMGL and DC-SIGN (as differentiation marker) on mo-DCs was confirmed by flow cytometry. (c) IL-6, IL-10 and TNFα levels on 
supernatants from Pam3CSK4 and LPS-stimulated mo-DC cultures incubated with and without FhTE. (D) moDCs were stimulated as in (B), in the presence of an 
anti-hMGL antibody or isotype control. A representative result of one out of four donors is shown (±SEM, indicated by error bars). Asterisks indicate statistically 
significant differences (*p < 0.05).
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deglycosylation to abolish hMGL recognition of FhTE. hMGL 
binding was abrogated in the presence of EGTA, GalNAc, and 
an anti-hMGL blocking antibody, while it was not modified by 
incubation with mannan or the isotype control (Figure  3A). 
F. hepatica glycoconjugates recognized by hMGL were identified 
by western blotting using hMGL-Fc as a group of components 
ranging from 50 to 100 kDa (Figure 3B). Interestingly, hMGL-Fc 
reactivity was inhibited in the presence of EGTA and after meta-
periodate oxidation of FhTE glycans (Figure 3B), confirming that 
the recognition of hMGL of FhTE glycoconjugates was glycan 
mediated. To confirm that GalNAc residues are present in FhTE, 
we carried out a lectin blot using the GalNAc-specific lectin from 
Vicia Villosa (VVL). VVL recognized molecular components with 
an apparent molecular weight pattern similar to that observed 
for hMGL (Figures  3B,C). Moreover, preincubation with the 
lectin VVL, but not ConA, two lectins that strongly interact with 
FhTE (10), inhibited the hMGL recognition, suggesting that 
VVL and hMGL interact with the same ligands present in FhTE 
(Figure 3D).
In order to establish the nature of the GalNAc-containing 
glycans present on FhTE that are recognized by hMGL, spe-
cific antibodies against the Tn antigen (αGalNAc-Thr/Ser), 
LDNF [GalNAcβ1-4(Fucα1-3)GlcNAc-R], LDN (GalNAcβ1-
4GlcNAc-R) and Lewisx [Galβ1-4(Fucα1-3)GlcNAc-R] were 
used. As shown in Figure 3E, only the anti-Tn and anti-GalNAc 
antibodies were able to reduce MGL binding to FhTE, while 
the blocking antibodies specific for the Lewisx, LDNF and LDN 
structures did not inhibit hMGL binding to FhTE (Figure 3E). 
In addition, hMGL binding to FhTE was inhibited after GalNAcase, 
but not mannase treatment of FhTE, indicating that hMGL rec-
ognizes terminal GalNAc residues present on FhTE (Figure 3F). 
Altogether, these results suggest that hMGL recognizes the Tn 
antigen present in FhTE.
The fact that MGL triggering induced by FhTE was only 
observed when FhTE was immobilized on plates suggests that 
MGL could recognize immobilized ligands present on the 
surface of the parasite. Thus, we investigated whether hMGL 
ligands are present in a tegumental extract of F. hepatica. 
FigUre 2 | FhTe induces Th2 polarization by reducing iFnγ and increasing il-4 production. moDCs were incubated with coated FhTE in the presence or 
absence of LPS (10 μg/ml) for 48 h and the expression of costimulatory molecules was evaluated by flow cytometry (a). To evaluate the capacity of the stimulated 
moDCs to polarize naïve CD4 T cells, cells were washed and incubated with CD4+ CD45RA+ T cells (ratio 1:10) in the presence of Staphylococcal Enterotoxin B 
(10 pg/ml). After 5 days, supernatants were harvested for the evaluation of IFNγ (B,c), and replaced with 100 U of IL-2. After 5 days, Th1/Th2 polarization of T cells 
was evaluated by intracellular staining of IFNγ and IL-4 after stimulation with PMA and Ionomycin in the presence of Brefeldin A (D–F). When indicated (c,F), 
moDCs were preincubated with an anti-hMGL antibody or an isotype control, before stimulation. IL-4/IFNγ ratio was evaluated relative to the control, based in single 
positive cells. Concentration of FhTE used: 200, 100, and 50 μg/ml. A representative result of one out of four donors is shown (±SEM, indicated by error bars). 
Asterisks indicate statistically significant differences (*p < 0.05).
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Indeed, hMGL recognized FhTeg in a Ca2+-dependent manner 
(Figure 3G).
mMgl2+ cD11c+ cells are recruited to 
the Peritoneum and liver of F. hepatica-
infected Mice
In order to get more insights into the recognition of F. hepatica 
glycoconjugates by MGL+ cells during parasite infection, we 
orally infected mice with F. hepatica metacercarie and analyzed 
the expression of mMGL1 and mMGL2 on cells from spleen, 
PECs, and liver after 3 wpi. Since mice possess two isoforms of 
the MGL receptor: mMGL1 and mMGL2 (15), we first evaluated 
whether they can recognize glycoconjugates present on FhTE 
by Western blotting. As shown in Figure  4A, only mMGL2 
recognized parasite components ranging from 37 to 100 kDa in 
migratory pattern similar to the one observed for hMGL, while 
mMGL1 did not recognize any F. hepatica components.
Interestingly, mMGL2+ cells significantly increased in infected 
mice, while no changes were observed in the percentage of 
mMGL1+ PECs (Figures 4B,C and Figure S3A in Supplementary 
Material). In contrast, when analyzing the total amount of cells, 
both mMGL1+ and mMGL2+ PECs increased in infected animals 
(Figure 4D), probably due to the great recruitment of cells in the 
peritoneum upon infection. On the other hand, both mMGL1+ and 
mMGL2+ cells were augmented in spleen (Figure 4E). Moreover, 
mMGL1 and mMGL2 expression evaluated by qRT-PCR in livers 
from infected and non-infected mice showed that both isoforms 
were overexpressed in this tissue during infection (Figure 4F). 
Finally, the recruitment of mMGL2+ cells was evaluated by 
FigUre 3 | characterization of FhTe glycoconjugates that are recognized by hMgl. (a) hMGL binding was evaluated on FhTE-coated plates with 
hMGL-Fc previously incubated with EGTA, mannan, GalNAc, anti-hMGL antibody, or isotype control. (B) Western Blot with hMGL-Fc on FhTE. Recognition of FhTE 
by hMGL was abrogated with EGTA and with periodate oxidation treatment of FhTE. (c) Lectin blot of FhTE using the GalNAc-specific lectin Vicia Villosa (VVL). (D) 
Inhibition of hMGL binding to plate-bound FhTE with the lectins VVL and ConA (1, 0.1, and 0.1 μg/ml). (e) Inhibition of hMGL binding to plate-bound FhTE with 
different carbohydrate-specific antibodies. (F) hMGL binding on FhTE-coated plates previously incubated with mannase or GalNAcase. (g) Binding of hMGL on 
membrane-associated parasite component-coated plates in presence (white bars) or absence (black bars) of EGTA. A representative figure of three or four 
independent experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically significant differences (*p < 0.05).
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microscopy on liver sections, indicating the presence of these 
cells in the leukocyte infiltrate of infected animals, but not control 
mice (Figure 4G and Figure S3B in Supplementary Material).
In order to characterize the mMGL2+ cell population present 
in the peritoneum of infected mice, we performed phenotype 
analyses by flow cytometry. As shown in Figure 5A, CD11c+ cells 
from infected mice, but not control mice, expressed mMGL2. 
These cells also expressed mMGL1, CD11b, SIRPα, and CD68, 
while they did not express CD8, Ly6G, Ly6C, CD3, or Siglec-F 
(Figure  5A). Furthermore, we observed that they were mainly 
characterized by a low expression of F4/80 (Figure  5B). Last, 
confocal microscopy of liver sections indicated that some of the 
mMGL2+ cells present in the leukocyte infiltrate of infected livers 
expressed CD11c (Figure 5C) and F4/80 (Figure 5D).
mMgl2+ cD11c+ cells from F. hepatica-
infected animals expand il-10-Producing 
cD4+ T cells and suppress Th1 immune 
responses
In order to establish whether mMGL2+ CD11c+ cells are immu-
nomodulated by F. hepatica, we first evaluated their capacity to 
take up parasite components and secrete cytokines. To this end, 
PECs from infected and non-infected animals were incubated 
FigUre 4 | mMgl2+ cells are recruited to the peritoneum during F. hepatica infection. (a) Recognition of mMGL1 and mMGL2 of FhTE by western blotting. 
(B) Evaluation by flow cytometry of mMGL1+ and mMGL2+ cells in the peritoneal cavity of infected and control mice. (c) Percentage of mMGL1+ or mMGL2+ cells in 
the peritoneum of infected and control mice. (D) Total cell numbers of mMGL1+ or mMGL2+ cells in the peritoneum of infected and control mice. (e) Percentage of 
mMGL1+ or mMGL2+ cells in the spleen of infected and control mice. (F) mRNA expression of mMGL1 and mMGL2 in the liver of infected and control animals. (g) 
MGL2 expression in livers of infected and control animals. A representative figure of three independent experiments is shown (±SD, indicated by error bars). 
Asterisks indicate statistically significant differences (*p < 0.05). The bar represents 100 μm.
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with Atto647-labeled FhTE and evaluated by flow cytometry in 
CD11c+ cells (Figure 6A). Peritoneal mMGL2+ CD11c+ cells from 
infected animals presented a higher capacity of FhTE internaliza-
tion than CD11c+ cells from non-infected animals. In addition, 
they expressed MHC II and CD86; while MHC II was expressed 
at lower levels than CD11c+ cells from non-infected mice, CD86 
was upregulated in MGL2+ cells from infected mice (Figure 6B). 
Furthermore, they produced higher transcript levels of the regu-
latory cytokines IL-10, TNFα, and TGFβ, while no differences 
were observed in the transcript levels of IL-6, IL-12/23p40, or 
IL-12p35 (Figures 6B,C), suggesting a potential regulatory role 
of these cells during infection.
Then, we evaluated the T-cell stimulatory capacity of 
mMGL2+ CD11c+ cells both in allogenic and syngenic cultures 
using purified CD4+ T  cells. mMGL2+ CD11c+ cells from 
infected animals induced the production of IL-10 and a decrease 
of IFNγ secretion by allogenic CD4+ T cells as compared with 
mMGL2− CD11c+ cells from non-infected animals (Figure 7A). 
Interestingly, mMGL2+ CD11c+ cells (but not naive mMGL2− 
CD11c+) enhanced the IL-10/IFNγ production ratio by CD4+ 
FigUre 5 | immunephenotyping of mMgl2+ cells in the peritoneum and in the liver of F. hepatica-infected animals. (a) Cells from the peritoneal cavity 
from infected or control mice were stained with CD11c-, mMGL1-, mMGL2-, CD11b-, CD8-, F4/80-, SIRPα-, CD68-, Ly6G-, Ly6C-, CD3-, and Siglec-F-specific 
antibodies and evaluated by flow cytometry. (B) Percentage of mMGL2+ CD11c+ F4/80+ or mMGL2+ CD11c+ F4/80low cells from PECs of infected animals. (c) 
Expression of MGL2+ and CD11c+ cells in the liver of infected mice. (D) Expression of MGL2+, CD11c+ and F4/80+ cells in the liver of infected mice. The bar 
represents 100 μm. A representative figure of three independent experiments is shown (±SD, indicated by error bars).
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FigUre 6 | characterization of cD11c+ mMgl2+ cells. CD11c+ cells were purified from the peritoneal cavity of infected mice at 3 wpi and naive mice. (a) 
Uptake was evaluated by flow cytometry on PECs previously incubated with different concentrations of Atto 647-labeled FhTE for 1 h at 37°C or 4°C as a control. 
Internalization is calculated as the difference between the MFI at 37°C and MFI at 4°C. (B) The expression of MHCII and CD86 and the production of IL-12/23p40 
and IL-10 by CD11c+ purified cells were evaluated by flow cytometry. (c) Expression of IL-6, IL-12p35, IL-10, TNFα, and TGFβ was evaluated by qRT-PCR on RNA 
obtained from purified CD11c+ cells. A representative figure of three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically 
significant differences (*p < 0.05).
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T cells (Figure 7A). Of note, the IL-10/IFNγ production ratio by 
CD4+ T cells was significantly increased when mMGL2+ CD11c+ 
cells were previously stimulated with coated FhTE (Figure 7A). 
mMGL2+ CD11c+ cells from infected animals also expanded 
specific CD4+ T cells that produced high levels of IL-10 in the 
absence of IFNγ (Figure 7B) and their function was enhanced 
when these cells were used with FhTE (Figure  7B), indicating 
that mMGL2+ CD11c+ cells induce IL-10hi IFNγlow CD4+ T cells, 
in both antigen-dependent and -independent manner. Last, we 
evaluated the capacity of mMGL2+ CD11c+ cells to suppress the 
induction of Th1 immune responses. To this end, purified splenic 
CD11c+ cells from naive mice were stimulated with PAM2CSK4 
and incubated with allogenic CD4+ T  cells in the presence or 
absence of mMGL2+ CD11c+ cells from infected mice. As shown 
in Figure 7C, mMGL2+ CD11c+ cells inhibited both the prolif-
eration and the production of IFNγ by CD4+ T cells. Altogether, 
these results show that mMGL2+ CD11c+ cells from infected 
mice expand IL-10 producing CD4+ T  cells and suppress Th1 
differentiation.
In order to deeply understand the immunoregulatory 
function of mMGL2+ CD11c+ cells from infected mice, we 
evaluated the expression of a variety of molecules that might 
participate in different DC functions and compare them with 
mMGL2− CD11c+  cells purified from naive control mice. 
CD11c+ cells from infected mice expressed high levels of 
mMGL2 and the MR than CD11c+ cells from control mice 
(Figure  8A). Moreover, these cells also expressed increased 
levels of Fizz-1 and Arg-1 (Figure 8B), commonly associated 
with alternative activated macrophages. However, no differ-
ences in the expression of inducible nitric oxide synthase, 
associated with a pro-inflammatory activation of macrophages 
was observed between CD11c+ cells from infected and control 
mice (Figure 8B). CD11c+ cells from infected mice also overex-
pressed CCL5 (Figure 8C), as well as other immunomodulatory 
molecules like the PD-L1 (Figure 8D) and the transcription fac-
tor interferon regulatory factor 4 (IRF4, Figure 8E), known to 
control Th2 cell differentiation. Altogether, our results suggest 
that MGL2+ CD11c+ cells are recruited to the peritoneal cav-
ity during F. hepatica infection, acquiring different regulatory 
markers associated to regulatory macrophages and potentially 
regulating the T cell polarization to a Th2/regulatory phenotype.
DiscUssiOn
In this work, we provide evidence that F. hepatica immune 
modulates CD11c+ MGL+ cells during infection and that they 
FigUre 7 | Functional analyses of cD11c+ mMgl2+ cells. (a) CD11c+ purified cells from the peritoneal cavity of infected or control mice were stimulated with 
FhTE-coated plates overnight at 37°C, washed and incubated with purified C57BL/6 CD4+ T cells from naive animals for 5 days at 37°C. IFNγ and IL-10 production 
by T cells was evaluated on culture supernatants by ELISA. (B) CD11c+ purified cells from the peritoneal cavity of infected or control mice were stimulated with FhTE 
overnight at 37°C, washed and incubated with purified BALB/c CD4+ T cells from 3-week-infected animals for 5 days at 37°C. IFNγ and IL-10 production by T cells 
was evaluated on culture supernatants by ELISA. Proliferation was evaluated on CFSE-stained CD4+ T cells by flow cytometry. The proliferation index was calculated 
as the ratio between the percentage of CFSElow CD4+ cells and CFSElow CD4+ cells with medium. (c) CD11c+ purified cells from the spleen of naïve BALB/c mice 
were stimulated with Pam2CSK4 in the presence or absence of FhTE overnight at 37°C, washed and incubated with purified C57BL/6 CD4+ T cells from naive 
animals for 5 days at 37°C in presence or absence of MGL2+ CD11c+ cells (100,000/well) from 3-week-infected animals. IFNγ production by T cells was evaluated 
on culture supernatants by ELISA. Proliferation was evaluated on CFSE-stained CD4+ T cells by flow cytometry. The proliferation index was calculated as the ratio 
between the percentage of CFSElow CD4+ cells and CFSElow CD4+ cells with medium. A representative figure of three independent experiments is shown (±SD, 
indicated by error bars). Asterisks indicate statistically significant differences (*p < 0.05).
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contribute to the expansion of IL-10-producing T  cells and 
the suppression of Th1-polarized immune responses. Parasite 
components also modulated the TLR-induced maturation of 
DCs through the binding of Tn carbohydrate structures to the 
C-type lectin MGL, indicating that this receptor is a key player 
in the immunoregulatory mechanisms triggered by F. hepatica. 
The capacity of MGL to act as a pattern recognition receptor has 
already been described. Indeed, MGL can recognize glycosylated 
molecules expressed by bacteria such as Neisseria gonorrhoeae 
(29), Bordetella pertussis (30), and Campylobacter jejuni (31, 32), 
as well as virus, including the Ebola (33) and Influenza (34). 
Furthermore, helminth-derived molecules can also interact 
with MGL. For instance, MGL recognizes S. mansoni through 
LacdiNAc residues (20, 35), while it binds T. suis through ter-
minal αGalNAc residues (21). These evidences, together with 
our results, highlight the role of MGL in mediating pathogen-
triggered immunoregulatory strategies.
We here show that the interaction with F. hepatica-derived 
molecules triggers MGL signaling that, together with TLR-
triggering, results in an enhanced production of IL-10 and 
FigUre 8 | expression of c-type lectin receptors, chemokines, and regulatory molecules by cD11c+ mMgl2+ cells. Expression by qRT-PCR of CLRs 
(a), macrophage markers (B), chemokines (c), regulatory membrane molecules (D), and IRF-4 (e) was evaluated on purified peritoneal CD11c+ cells from infected 
(black bars) and control (white bars) mice. A representative figure of three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate 
statistically significant differences (*p < 0.05).
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TNFα. While the MGL-induced production of IL-10 and 
TNFα by human MGL+ DCs has already been described 
(28, 36), this is the first report demonstrating that the Tn 
antigen present in F. hepatica components interacts with MGL 
on DCs and favors Th2 polarization. It is well known that 
IL-10 is a cytokine with potent anti-inflammatory properties 
that plays a central role in limiting host immune response 
to pathogens. Also, TNFα, although classically grouped as a 
pro-inflammatory cytokine, can have inhibitory properties, 
especially when associated with IL-10. Indeed, tolerogenic 
DCs generated in the presence of vitamin D3, secrete high 
amounts of both IL-10 and TNFα after LPS activation and 
favor the expansion of regulatory T cells in a TNFα-dependent 
manner (37). MGL+ DCs can also instruct the differentiation 
of T cells toward Tr1 regulatory cells in an IL-10-dependent 
manner (36). This phenomenon could constitute a mechanism 
used by F. hepatica to evade immunity, as has already been 
proposed for C. jejuni, where MGL inhibits the upregulation 
of DC-maturation marker expression and limits production 
of the pro-inflammatory cytokine IL-6 (31).
However, most of the published studies describe the immu-
nomodulatory role of MGL in in  vitro settings. In order to 
evaluate whether MGL plays a role in DC immunomodulation 
during infection with F. hepatica, we analyzed the phenotypic 
and functional characteristics of MGL+ DC in F. hepatica-
infected mice. Although both mMGL1+ and mMGL2+ cells 
increased in the peritoneal cavity, spleen, and liver of infected 
mice, the proportion of mMGL2+ cells were clearly augmented 
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both in PEC, spleen, and liver, suggesting either a recruitment 
of these cells or a strong increase of mMGL2 expression induced 
during the infection. Of note, the tolerogenic stimulus dexa-
methasone induced the expression of hMGL on mo-DCs during 
DC-differentiation (24), suggesting a role in the development or 
maintenance of tolerance. In this scenario, we could speculate 
that mMGL2, but not mMGL1, seems to have a role during the 
infection process, since only mMGL2 was able to recognize 
parasite components.
Upon F. hepatica infection, we detected a recruitment of 
mMGL2+ cells in the peritoneum. These cells also expressed 
mMGL1, CD11c, CD11b, SIRPα, and CD68. However, they 
expressed low levels of F4/80, often used as macrophage marker 
(38), but also expressed by inflammatory DCs and CD11b line-
age DCs (39). Similarly, although CD68 is highly expressed by 
monocytes and tissue macrophages, it can also be present to a 
lesser extent on DCs and peripheral blood granulocytes (40). 
Since CD68 has been implicated in the mediation, recruitment, 
and activation of macrophages (41, 42), it would be interesting 
to determine whether it can participate in the recruitment of 
mMGL2+ cells to the peritoneum or liver of infected mice. 
Furthermore, the phenotype found for mMGL2+ cells in 
F. hepatica-infected mice suggests that they might correspond 
to DCs since the same phenotype was described in mMGL1+ 
mMGL2+ cells in lung, spleen, and bone marrow from naïve 
mice, while mMGL1 is expressed by a heterogeneous group of 
cells including, macrophages, cDC, and pDC (19). Experiments 
evaluating the expression of macrophage-specific molecules in 
mMGL2+ cells during F. hepatica infection, such as CD64 and 
MerTK (40), will determine whether these cells are macrophages 
or DCs.
mMGL2+ CD11c+ cells also expressed signal regulatory 
protein α (SIRPα), a regulatory membrane glycoprotein abun-
dant in DCs, macrophages, and neutrophils that participates in 
immune homeostasis (43). It has been proposed that SIRPα+ 
DCs can regulate immune responses through its cytoplasmic 
region containing immunoreceptor tyrosine-based inhibi-
tion motifs. Indeed, SIRPα+ DCs can promote Th2-mediated 
allergic inflammation (44) and participate in the development 
of central tolerance against circulating peripheral antigens (45). 
In addition, ligation of SIRPα to its ligand CD47 suppresses 
DC maturation and inhibits cytokine production by mature 
DCs (46), suggesting that SIRPα can prevent activation of DCs. 
Peritoneal mMGL2+ CD11c+ cells were also characterized by 
decreased levels of MHCII, but increased expression of CD86, 
corresponding to the semi-mature phenotype of DCs already 
described for F. hepatica (10).
During F. hepatica infection, the mMGL2+ CD11c+ cells 
seem to acquire a regulatory program that activates specific 
IL-10-producing CD4+ T  cells that correlates with the T  cell 
response already described in animals infected with this 
parasite (4, 5, 10). Indeed, mMGL2+ CD11c+ cells, but not 
mMGL2− CD11c+ cells from non-infected mice, produced the 
inmmunoregulatory cytokines TGFβ, IL-10, and TNFα that 
were associated with their capacity to activate IL-10-producing 
both allogenic and syngenic CD4+ T cells. Finally, FhTE-loaded 
mMGL2+ CD11c+ cells induced higher production of IL-10 
by both allogenic and syngenic CD4+ T  cells, suggesting that 
parasite components enhance the immunoregulatory program 
on DCs that regulate DC maturation and stimulatory func-
tion. Several reports are in agreement with our results, having 
already described that murine MGL2+ DCs are required for 
efficient Th2 development of mice infected with the hookworm 
Nippostrongylus brasiliensis (47). In addition, human MGL+ 
DCs exposed to N. gonorrhoeae LPS carrying a terminal 
GalNAc residue are prone to induce Th2-type T  cells (29). 
Taken together, these and our observations suggest that 
MGL+ DCs induce and/or expand Th2 immune responses by 
 triggering  MGL.
The capacity of mMGL2+ CD11c+ cells to induce IL-10-
producing T  cells was associated to the expression of FIZZ1 
and IRF4 by these cells. FIZZ1 is induced during Th2 cytokine 
immune response upon helminth infection (48), and, although 
most commonly associated with alternatively activated mac-
rophages, it can also be expressed by DCs from mice infected with 
Brugia malayi (49). IRF4 is a transcription factor expressed on 
DCs necessary for Th2 differentiation, but not for Th1 immune 
responses (50). Interestingly, IRF4 also regulates the differen-
tiation of murine mMGL2+ DCs, including mMGL2+ dermal 
DCs, splenic CD8α− CD11bhi DCs, as well as M2-macrophage 
polarization (51–53). Furthermore, IRF4 has been shown to bind 
to the IL-10 gene promoter and induces its expression in Th2 
and Treg cells (54–57). Given the fact that peritoneal mMGL2+ 
CD11c+ cells from infected mice expressed IRF4 and that they 
induced the production of IL-10 by CD4+ T cells makes it highly 
likely that the production of IL-10 induction is driven by IRF4. 
Nevertheless, additional experiments are necessary to corrobo-
rate this hypothesis.
Our results also indicate that mMGL2+ CD11c+ cells present 
a higher capacity to internalize parasite molecules, as compared 
to mMGL2− CD11c+ cells from control mice, explained by the 
increased expression of MGL or MR. This enhanced uptake 
could favor antigen presentation and the activation of specific 
CD4+ T cells (58). In addition, MR was recently described to 
interact with F. hepatica molecules and to mediate the partial 
inhibition of TLR-induced maturation of bone marrow-derived 
DCs (59, 60), suggesting that the parasite targets more than 
one CLR to evade immunity. Indeed, other CLRs, such as 
MR and Dectin-1, have been reported to immunomodulate 
Arginase-1 and PDL-2 expression and TGFβ production by 
macrophages in response to F. hepatica excretory–secretory 
products (61, 62).
On the other hand, mMGL2+ CD11c+ cells from infected 
animals suppressed the differentiation of Th1  cells induced by 
PAM2CSK4-stimulated DCs. These results are in agreement 
with previous data showing that CD11c+ mMGL2+ dermal DCs 
express lower levels of molecules involved in Th1-type immunity 
compared to CD103+ mMGL2− dermal DCs (63). The Th1-
suppressive capacity of mMGL2+ CD11c+ cells correlated with 
the high expression of Arg-1, PD-L1, and CCL5 (also known as 
RANTES) by these cells. Arg-1 has been shown to impair T cell 
responses by reducing the bioavailability of l-arginine and pro-
moting l-arginine starvation (64). Moreover, suppressive DCs 
can upregulate Arg-1 expression (65). Murine mMGL2+ CD11c+ 
FigUre 9 | schematic illustration summarizing the main findings in the present study. The Tn antigen on F. hepatica interacts with MGL expressed on the 
DC surface, triggering a regulatory program together with TLR signaling that induces enhanced expression of TNFα and IL-10 by DCs and a Th2/regulatory T cell 
polarization.
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cells also upregulated PD-L1, which is together with PD-L2, 
the ligand of PD-1, an immune inhibitor receptor expressed on 
T cells that limits/controls cell proliferation serves to maintain 
immune homeostasis (66). Moreover, deficiency of PD-L1 boosts 
immune responses (67). PD-L1 on DCs could play a role in 
controlling the induction of parasite-specific immunity to allow 
its survival. Finally, CCL5 is a chemokine that attracts T  cells 
eosinophils and basophils, and it recruits leukocytes to the site 
of infection (68). Interestingly, helminth infections are associ-
ated with high levels of CCL5, among other pro-inflammatory 
chemokines (26, 69), and in particular, by DCs (49). However, the 
pro-inflammatory function of CCL5 is inversely correlated with 
its extracellular levels. At low levels, RANTES serves to promote 
the recruitment of leukocytes to the site of inflammation, while 
at high levels, CCL5 stops acting as a chemokine and has direct 
immunostimulatory and proapoptotic activities (68). The direct 
function of these molecules during F. hepatica infection remains 
to be investigated.
In conclusion, although inflammation-promoting aspects of 
MGL, especially for mMGL1, have been reported, considering 
the results presented in the study and based on the fact that 
MGL-induced the IL-10-mediated differentiation of Tr1 cells 
by DCs, we suggest that F. hepatica triggers anti-inflammatory 
properties of MGL that lead a regulation both of innate and 
adaptive parasite immunity (Figure 9). mMGL2+ CD11c+ cells 
expressing regulatory molecules (IL-10, TGFβ, PD-L1, Sirpα, 
Arg-1, and FIZZ1) are recruited to the peritoneum and liver of 
infected mice where they could expand specific Th2 and Treg 
cells and suppress Th1 polarization. To our knowledge, this is 
the first report that provides evidences about the involvement 
of MGL during a helminth infection and to the generation 
of Th2 and regulatory T  cell response induced by F. hepatica. 
Moreover, this work constitutes the first report that recapitulates 
the in vitro findings on human MGL in an in vivo mouse model, 
showing that human MGL and mouse MGL2 may induce similar 
responses.
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